Document is current
Any future updates will be listed below
-
Authors
Tang, Shiying https://orcid.org/0000-0002-5095-4158
Che, Xiaofang
Wang, Jinyan
Li, Ce
He, Xin
Hou, Kezuo
Zhang, Xiaojie
Guo, Jia
Yang, Bowen
Li, Danni
Cao, Lili
Qu, Xiujuan
Wang, Zhenning https://orcid.org/0000-0003-0557-3097
Liu, Yunpeng https://orcid.org/0000-0002-9645-7990
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81972751, 32170791, 81972331)
National Key Research and Development Program of China
Research Project of Education Department of Liaoning Province
Noncommunicable Chronic Diseases-National Science and Technology Major Project
- License Information
-
More Information
Article History
Received: 25 April 2024
Accepted: 4 April 2025
First Online: 25 April 2025
Competing interests
: X.C., X.Q., Y.L., and S.T. declare a pending patent (P012510580) regarding T-bet+ CD8 + T cells as a therapeutic biomarker in GI cancers. The remaining authors declare no competing interests.
